Early to moderate type 2 diabetes For patients with type 2 diabetes who have not achieved adequate control with metformin alone, GLP-1 receptor agonists are increasingly the second-line choice
You feel dizzy, faint, or experience a racing heart alongside the temperature changes
Wang XH, Li L, Holscher C, Pan YF, Chen XR, Qi JS
[42], while GLP-1 agonists are highly effective for managing T2D and supporting WL, BS remains superior in achieving long-term diabetes remission
Retrieved 25 March 2018
Market reports show that the global glutathione sector is expanding at an annual growth rate of around 89%, with skincare and personal care applications identified as one of the fastest-growing segments for anti-aging raw materials and active ingredients